title: Characterization of antidiabetic and antihypertensive properties of canary seed (Phalaris canariensis L.) peptides.
abstract: Canary grass is used as traditional food for diabetes and hypertension treatment. The aim of this work is to characterize the biological activity of encrypted peptides released after gastrointestinal digestion of canary seed proteins. Canary peptides showed 43.5% inhibition of dipeptidyl peptidase IV (DPPIV) and 73.5% inhibition of angiotensin-converting enzyme (ACE) activity. An isolated perfused rat heart system was used to evaluate the canary seed vasoactive effect. Nitric oxide (NO), a major vasodilator agent, was evaluated in the venous effluent from isolated perfused rat heart. Canary seed peptides (1 μg/mL) were able to induce the production of NO (12.24 μM) in amounts similar to those induced by captopril (CPT) and bradykinin (BK). These results show that encrypted peptides in canary seed have inhibitory activity against DPPIV and ACE, enzymes that are targets for diabetes and hypertension treatments.
authors.affiliation: IPICyT, Instituto Potosino de Investigación Cientı́fica y Tecnológica A.C., Camino a la Presa San José No. 2055, Lomas 4a sección, 78216 San Luis Potosı́, S.L.P., Mexico.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Estrada-Salas
authors.forename: Gabriela M
authors.initials: GM
authors.lastname: Montero-Morán
authors.forename: Pedro P
authors.initials: PP
authors.lastname: Martínez-Cuevas
authors.forename: Carmen
authors.initials: C
authors.lastname: González
authors.forename: Ana P
authors.initials: AP
authors.lastname: Barba de la Rosa
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001920:Bradykinin; D002216:Captopril; D003331:Coronary Vessels / Q000187:drug effects; D004063:Digestion; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009569:Nitric Oxide / Q000032:analysis / Q000096:biosynthesis; D010455:Peptides / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D031783:Phalaris / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar; D055314:Seed Storage Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D012639:Seeds / Q000737:chemistry*; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D010455:Peptides; D055314:Seed Storage Proteins; D014665:Vasodilator Agents; D009569:Nitric Oxide; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D001920:Bradykinin
keywords: angiotensin-converting enzyme; canary seed; dipeptidyl peptidase IV; encrypted peptides; nitric oxide